• Agastha Version 15.1 Drummond Certified – 2015 Edition Certification

    ONC Mandatory Disclosures
    Agastha Version 15.1was 2015 edition certified under Drummond Group’s Electronic Health Records Office of the National Coordinator Authorized Certification Body (ONC-ACB) program on 12/31/2017.
    Drummond Group’s ONC-ACB certification program certifies that EHRs meet the meaningful use criteria for either eligible provider or hospital technology. In turn, healthcare providers using the EHR systems of certified vendors are qualified to receive federal stimulus monies upon demonstrating meaningful use of the technology.
    Agastha solution is cloud-based and compliant.

    CHPL Product Number : 15.04.04.1056.Agas.14.00.1.171231
    ONC-ACB Certification ID : 15.04.04.1056.Agas.14.00.1.171231
    Developer                                : Agastha, Inc
    Date Certified                         : 12/31/2017
    Product Name/ Version          : Agastha Enterprise Healthcare Software / 15.1
    Certificate No                          : 02052015-3117-3
    Effective Date                          : 2015 Edition

    Contact information : 
    First name: Eddy
    Last name: Dishueme
    Email: Eddy@agastha.com
    Phone: 704-544-6504
    Address: 11540 N.Community House Road, Suite 100
    Charlotte, NC 28277

    Criteria to which Agastha EHR is certified: 
    170.315 (a)(1): Computerized Provider Order Entry (CPOE)
    170.315 (a)(2): CPOE - Laboratory
    170.315 (a)(3): CPOE - Diagnostic Imaging
    170.315 (a)(4): Drug-Drug, Drug-Allergy Interaction Checks for CPOE
    170.315 (a)(5): Demographics
    170.315 (a)(6): Problem List
    170.315 (a)(7): Medication List
    170.315 (a)(8): Medication Allergy List
    170.315 (a)(9): Clinical Decision Support
    170.315 (a)(10): Drug-Formulary and Preferred Drug List Checks
    170.315 (a)(11): Smoking Status
    170.315 (a)(12): Family Health History
    170.315 (a)(13): Patient-Specific Education Resources
    170.315 (a)(14): Implantable Device List
    170.315 (b)(1): Transitions of Care
    170.315 (b)(2): Clinical Information Reconciliation and Incorporation
    170.315 (b)(3): Electronic Prescribing
    170.315 (b)(6): Data Export
    170.315 (c)(1): Clinical Quality Measures - Record and Export
    170.315 (c)(2): Clinical Quality Measures - Import and Calculate
    170.315 (c)(3): Clinical Quality Measures - Report
    170.315 (d)(1): Authentication, Access Control, Authorization
    170.315 (d)(2): Auditable Events and Tamper-Resistance
    170.315 (d)(3): Audit Report(s)
    170.315 (d)(4): Amendments
    170.315 (d)(5): Automatic Access Time-out
    170.315 (d)(6): Emergency Access
    170.315 (d)(7): End-User Device Encryption
    170.315 (d)(8): Integrity
    170.315 (d)(9): Trusted Connection
    170.315 (d)(11): Accounting of Disclosures
    170.315 (e)(1): View, Download, and Transmit to 3rd Party
    170.315 (e)(2): Secure Messaging
    170.315 (e)(3): Patient Health Information Capture
    170.315 (f)(1): Transmission to Immunization Registries
    170.315 (f)(2): Transmission to Public Health Agencies - Syndromic Surveillance
    170.315 (f)(4): Transmission to Cancer Registries
    170.315 (f)(7): Transmission to Public Health Agencies - Health Care Surveys
    170.315 (g)(2): Automated Measure Calculation
    170.315 (g)(3): Safety-Enhanced Design
    170.315 (g)(4): Quality Management System
    170.315 (g)(5): Accessibility-Centered Design
    170.315 (g)(6): Consolidated CDA Creation
    170.315 (g)(7): Application Access - Patient Selection
    170.315 (g)(8): Application Access - Data Category Request
    170.315 (g)(9): Application Access - All Data Request

    Clinical Quality Measures to which Agastha EHR is certified: 
    CMS50: Closing the Referral Loop: Receipt of Specialist Report
    CMS62: HIV/AIDS: Medical Visit
    CMS65: Hypertension: Improvement in Blood Pressure
    CMS68: Documentation of Current Medications in the Medical Record
    CMS74: Primary Caries Prevention Intervention as Offered by Primary Care Providers, including Dentists
    CMS75: Children Who Have Dental Decay or Cavities
    CMS77: HIV/AIDS: RNA control for Patients with HIV
    CMS122: Diabetes: Hemoglobin A1c (HbA1c) Poor Control (> 9%)
    CMS123: Diabetes: Foot Exam
    CMS124: Cervical Cancer Screening
    CMS125: Breast Cancer Screening
    CMS126: Use of Appropriate Medications for Asthma
    CMS127: Pneumococcal Vaccination Status for Older Adults
    CMS130: Colorectal Cancer Screening
    CMS131: Diabetes: Eye Exam
    CMS137: Initiation and Engagement of Alcohol and Other Drug Dependence Treatment
    CMS138: Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention
    CMS139: Falls: Screening for Future Fall Risk
    CMS146: Appropriate Testing for Children with Pharyngitis
    CMS148: Hemoglobin A1c Test for Pediatric Patients
    CMS153: Chlamydia Screening for Women
    CMS154: Appropriate Treatment for Children with Upper Respiratory Infection (URI)
    CMS155: Weight Assessment and Counseling for Nutrition and Physical Activity for Children and Adolescents
    CMS156: Use of High-Risk Medications in the Elderly
    CMS157: Oncology: Medical and Radiation - Pain Intensity Quantified
    CMS158: Pregnant women that had HBsAg testing
    CMS161: Adult Major Depressive Disorder (MDD): Suicide Risk Assessment
    CMS163: Diabetes: Low Density Lipoprotein (LDL-C) Control (< 100 mg/dL)
    CMS164: Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antiplatelet CMS165: Controlling High Blood Pressure
    CMS166: Use of Imaging Studies for Low Back Pain
    CMS177: Child and Adolescent Major Depressive Disorder (MDD): Suicide Risk Assessment

    Additional software use demonstrate compliance with certification criteria : None

    ONC Disclaimer : “This Health IT Module is 2015 Edition compliant and has been certified by an ONC-ACB in accordance with the applicable certification criteria adopted by the Secretary of Health and Human Services. This certification does not represent an endorsement by the U.S. Department of Health and Human Services.”

    Price Transparency Statement : 
    Additional costs for certified capabilities: This product does not have any fees associated with the ONC certified features but there are costs to enable and support the use of capabilities disclosed below:
       » Ongoing monthly costs to support online patient service (170.315.e.1).
       » One-time costs to establish interfaces for reporting to immunization registries, cancer registries, and public health agencies (170.315.f.1, 170.315.f.2, 170.315.f.4, 170.315.f.7).
       » One-time costs to integrate with other ONC certified systems.
    There are no contracting requirements to use the product.

    Limitations : There are no contractual limitations related to Agastha that would limit the user’s ability to use any of the certified capabilities.

  • Meaningful Use-2 Certified

    ONC Disclaimer : “This Complete EHR certification is 2014 Edition compliant and has been certified by an ONC-ACB in accordance with the applicable certification criteria adopted by the Secretary of the U.S. Department of Health and Human Services. This certification does not represent an endorsement by the U.S. Department of Health and Human Services or guarantee the receipt of incentive payments.”


    Organization Name                : Agastha, Inc
    Date Certified                         : 02/05/2015
    Product Name/ Version          : Agastha Enterprise Healthcare Software / 10.2.012015
    Certificate No                          : 02052015-3117-3
    Effective Date                          : 2014 Edition


    Modules Tested : 170.314(a)(1-15); 170.314(b)(1-5, 7); 170.314(c)(1-3); 170.314(d)(1-9); 170.314(e)(1-3); 170.314(f)(1-3, 5, 6); 170.314(g)(2, 3, 4)


    Certified Clinical Quality Measures : 2v3; 22v2; 50v2; 52v3; 56v3; 61v4; 62v3; 64v4; 65v4; 66v3; 68v3; 69v2; 74v4; 75v2; 77v3; 82v2; 90v3; 117v2; 122v2; 123v3; 124v2; 125v2; 126v2; 127v2; 128v3; 129v3; 130v2; 131v3; 132v3; 133v3; 134v2; 135v3; 136v3; 137v2; 138v2; 139v2; 140v2; 141v3; 142v3; 143v3; 144v3; 145v3; 146v2; 147v2; 148v2; 149v3; 153v2; 154v2; 155v2; 156v2; 157v2; 158v3; 159v3; 160v3; 161v2; 163v2; 164v2; 165v2; 166v3; 167v3; 169v3; 177v2; 179v3; 182v4


    Additional Software Required : None


    Price Transparency Statement : 
    Additional costs for certified capabilities:This product does not have any fees associated with the ONC certified features but there are costs to enable and support the use of capabilities disclosed below:
       » Ongoing monthly costs to support online patient service (170.314.e.1).
       » One-time costs to establish interfaces for reporting to immunization registries, cancer registries, and public health agencies (170.314.f.2, 170.314.f.4, 170.314.f.6).
       » One-time costs to integrate with other ONC certified systems.
    There are no contracting requirements to use the product.


    Limitations : There are no contractual limitations related to Agastha that would limit the user’s ability to use any of the certified capabilities.

    The Agastha EHR is certified according to the criteria in 170.315(b)(7). The ability to generate CCDAs in bulk for all patients is enabled.

    The Agastha EHR is certified according to the criteria in 170.314(e)(1). This measure implies the ability to submit summaries of care to a third party via a direct message as a referral. Due to limited adoption of Direct messaging, providers may not have the full capabilities of this measure.